These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12506033)

  • 1. JunB gene expression is inactivated by methylation in chronic myeloid leukemia.
    Yang MY; Liu TC; Chang JG; Lin PM; Lin SF
    Blood; 2003 Apr; 101(8):3205-11. PubMed ID: 12506033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia.
    Hoshino K; Quintás-Cardama A; Radich J; Dai H; Yang H; Garcia-Manero G
    Leuk Res; 2009 Oct; 33(10):1361-6. PubMed ID: 19409613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylation status of JunB and CDH13 gene promoter in CD34(+)CD38(-) chronic myelogenous leukemia cells].
    Wang XJ; Li J; Fu BJ; Guo LL; Zhang JH; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1405-8. PubMed ID: 20030915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of quantitative assessment of JunB gene expression as a marker for monitoring chronic myeloid leukemia patients undergoing imatinib therapy.
    Liu YC; Hsiao HH; Chang JG; Yang MY; Liu TC; Chang CS; Tseng SB; Tsai HJ; Lin SF
    Int J Hematol; 2006 Dec; 84(5):425-31. PubMed ID: 17189224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3.
    Yang MY; Chang JG; Lin PM; Tang KP; Chen YH; Lin HY; Liu TC; Hsiao HH; Liu YC; Lin SF
    Cancer Sci; 2006 Dec; 97(12):1298-307. PubMed ID: 16999817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
    Ando T; Nishimura M; Oka Y
    Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation does not regulate JUNB expression in CML: comment on "Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia" by Hoshino et al. [Leuk. Res. 33 (2009) 1361-1366].
    Strathdee G; Ferguson S; Sim A; Brown R
    Leuk Res; 2010 May; 34(5):685-6. PubMed ID: 20006998
    [No Abstract]   [Full Text] [Related]  

  • 9. GPX3 promoter is methylated in chronic myeloid leukemia.
    Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J
    Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
    Yang H; Liang H; Yan JS; Tao R; Hao SG; Ma LY
    Int J Hematol; 2012 Jul; 96(1):65-73. PubMed ID: 22674382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Haematologica; 2007 Feb; 92(2):153-62. PubMed ID: 17296563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
    Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
    Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
    Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of PLCD1 in chronic myeloid leukemia.
    Song JJ; Liu Q; Li Y; Yang ZS; Yang L; Xiang TX; Ren GS; Chen JB
    Int J Mol Med; 2012 Jul; 30(1):179-84. PubMed ID: 22576628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-aza-2'-deoxycytidine-mediated c-myc Down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia.
    Grandjenette C; Schnekenburger M; Karius T; Ghelfi J; Gaigneaux A; Henry E; Dicato M; Diederich M
    Neoplasia; 2014 Jun; 16(6):511-28. PubMed ID: 24970385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB1 regulation through LRPPRC is influenced by the methylation status of the GC -100 box in its promoter.
    Corrêa S; Binato R; Du Rocher B; Ferreira G; Cappelletti P; Soares-Lima S; Pinto LF; Mencalha A; Abdelhay E
    Epigenetics; 2014 Aug; 9(8):1172-83. PubMed ID: 25089713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia].
    Jochum W; Passegue E; Wagner EF
    Verh Dtsch Ges Pathol; 1999; 83():216-7. PubMed ID: 10714213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
    Annamaneni S; Kagita S; Gorre M; Digumarti RR; Satti V; Battini MR
    Hematology; 2014 Jan; 19(1):42-4. PubMed ID: 23541085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.